1800 202 8726
When age shapes the decision

Prostate Biopsy in Older Men: — Is It Always Worth Doing?

When a doctor suggests a prostate biopsy for an older man, the first question most families ask is whether it is worth it. The honest answer is: sometimes yes, sometimes no — and the right question to ask first is what would actually change if the result came back positive.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

  • No fixed age cutoff — There is no age at which a biopsy becomes automatically inappropriate — but age changes how the decision is made.
  • The result has to change something — If a diagnosis would not lead to any treatment, the reason for the biopsy needs to be clearly understood first.
  • Infection risk is real — Prostate biopsy carries a recognised infection risk, and the route chosen affects how significant that risk is.
  • Your priorities are part of the decision — Wanting to know — or not wanting to know — is a legitimate part of the conversation, not a wrong answer.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

There is no age limit for a prostate biopsy, but age changes how the decision is made. NCCN guidance frames the question around life expectancy and whether a diagnosis would change your treatment plan. For some older men it would. For others, the honest answer is that it might not — and that is a reason to discuss before agreeing.

Is there an age limit for prostate biopsy?

There is no fixed age at which a biopsy is automatically ruled out. Your urologist considers your overall health, your other medical conditions, and — most importantly — what the result would actually change about your care.

NCCN guidelines frame this around life expectancy and treatment fitness rather than age alone. A man of 75 in excellent health with no other serious conditions is in a very different position from a man of 75 managing several significant illnesses.

The question is not how old you are. The question is whether a confirmed diagnosis would lead to a treatment you are fit enough to receive and would actually want.

What do these terms mean when your doctor uses them?

Life expectancy (in this context)
Not a prediction of exactly how long you will live. It is a clinical estimate of whether your health gives enough time for a prostate cancer — which is often slow-growing — to affect you, and for treatment to help rather than harm.
Active surveillance
Monitoring a confirmed low-risk prostate cancer with regular PSA tests and repeat checks instead of treating it immediately. Offered when the cancer is unlikely to cause harm within a man's expected lifetime.
Watchful waiting
A less intensive monitoring approach, usually chosen for older men or those with significant other health problems, where the aim is to manage symptoms if they arise rather than to treat the cancer itself.
Shared decision-making
A structured conversation where your priorities — not just the clinical numbers — shape the recommendation. The doctor brings the evidence. You bring what matters to you.

What if treatment would not change, whatever the result shows?

This is the question that should be asked before the biopsy, not after it. If your urologist has already concluded that your health would not support surgery, radiation or hormone therapy, it is worth understanding what you would do with a positive result.

That does not mean the answer is always no. Some men want to know. Knowing can end months of uncertainty, help with future planning, or make sense of symptoms that have gone unexplained. Those are real and valid reasons.

But if knowing would not change your treatment, your monitoring plan, or your peace of mind in any meaningful way, it is entirely reasonable to ask your doctor to explain what purpose the biopsy serves. A good urologist will welcome that question.

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

What should you ask your urologist before agreeing to a biopsy?

  • What would change about my care if the result is positive?
  • What would change if the result is negative?
  • Am I fit enough to receive treatment if cancer is confirmed?
  • Which biopsy route do you recommend, and why?
  • What is the infection risk, and what signs mean I should call you afterwards?
  • Is there an imaging test we could do first before deciding on a biopsy?
  • What happens if we choose to monitor rather than investigate right now?

What older men and their families ask most

Does a rising PSA always mean cancer — especially in older men?

No. PSA rises naturally with age because the prostate gland itself tends to enlarge over time, and this raises the level without any cancer being present. Infection, inflammation, and a condition called benign prostatic hyperplasia can all raise PSA substantially. A rising PSA is a reason to investigate further, not a diagnosis in itself. Your urologist will look at the pattern of the rise, your symptoms, and the physical examination before deciding whether a biopsy is the right next step.

What is the infection risk from a prostate biopsy, and is it higher in older men?

Prostate biopsy carries a recognised risk of infection, including a serious bloodstream infection called sepsis, which is one of the most significant complications of the procedure. The transrectal route — where the needle passes through the bowel wall — carries a higher infection risk than the transperineal route, which passes through the skin and avoids the bowel entirely. NCCN and EAU guidance increasingly supports the transperineal approach for this reason. Ask your urologist which route they use and what symptoms after the procedure would mean you need urgent care.

What if my father wants the biopsy even though treatment is unlikely?

That is his right, and it is a reasonable choice. Wanting to know your diagnosis — even if it does not change the treatment plan — is a legitimate reason for a biopsy. Some men find uncertainty harder to manage than a confirmed result. Others want to understand what they are dealing with for their own planning, or to close a question that has been open for years. If your father has been told his health makes treatment unlikely and still wants to proceed, his urologist should support that decision and explain the risks clearly so he can give informed consent.

Is there a less invasive way to check before going straight to biopsy?

Yes, and this is worth asking about. A multiparametric MRI of the prostate — often called mpMRI — can identify areas that look suspicious and help decide whether a biopsy is needed at all, and if so, which part of the prostate to target. EAU and NICE guidance supports offering mpMRI before biopsy in many cases, because it can reduce unnecessary biopsies and improve the accuracy of those that are done. Availability varies across centres, and your urologist will advise on whether it is appropriate for your situation.

Does 'life expectancy' mean the doctor is giving up on him?

No, and this misunderstanding causes real distress. When a doctor raises life expectancy in this context, they are asking a clinical question: is there enough time for a slow-growing cancer to cause harm, and enough health reserve for treatment to help rather than harm? It is a calculation about timing and fitness, not a judgement about worth or effort. A doctor who asks this question carefully is doing their job — they are making sure the risks of the procedure are worth taking given what can realistically be offered on the other side of a positive result.

Did you know?

Prostate cancer that causes no symptoms and shortens no life is far more common in older men than most people realise. Autopsy studies cited in EAU and ESMO guidelines have consistently found cancer in the prostates of older men who died of entirely unrelated causes.

This is one reason the decision to investigate is not the same as the decision to treat — and why the first question is always: what would we do with a confirmed diagnosis?

Source: European Association of Urology (EAU) Guidelines on Prostate Cancer

Explore 133 more Biopsy by Body Part topics

HUB — Biopsy by Body Part

All Biopsy by Body Part →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Is there an age after which prostate biopsy is not recommended?

No international guideline sets a specific age at which biopsy is automatically ruled out. NCCN and EAU guidance frames the decision around life expectancy and treatment fitness rather than age alone. A man in his late seventies who is otherwise healthy and would be a candidate for treatment is in a very different position from a man of the same age managing multiple serious illnesses. Age matters, but it is one factor among several — not a cutoff in either direction.

What are the main risks of a prostate biopsy in an older man?

The main risks are infection — including a potentially serious bloodstream infection called sepsis — bleeding, and temporary urinary difficulty. The infection risk is higher with the transrectal route, where the needle passes through the bowel wall, and lower with the transperineal route, which avoids the bowel. Older men with other health conditions may also carry additional risk from any sedation used. Your urologist will review your specific situation and explain which route they recommend and why.

My father is 80 and his PSA has been rising for two years. Does he need a biopsy?

A rising PSA at 80 is a reason to have a careful conversation with a urologist — not necessarily a reason to book a biopsy immediately. The conversation should cover what a positive result would lead to, whether your father's health makes him a candidate for treatment, and what he wants to know. If he is well and treatment is realistic, investigation is reasonable. If his health means treatment is unlikely, the discussion shifts to whether a confirmed diagnosis would serve any purpose he values.

Can the decision about a biopsy be revisited later if we say no now?

Yes. Declining a biopsy now does not close the question permanently. PSA can be monitored, and if there is a significant change in symptoms, a notable rise in PSA, or a change in health that affects what treatment would be possible, the decision can be looked at again. This is one reason active PSA monitoring is offered as a middle path — it keeps the question open without requiring an immediate decision to investigate.

What is an mpMRI and should we ask about it before agreeing to a biopsy?

A multiparametric MRI — mpMRI — is an imaging test of the prostate that can identify areas of concern before a biopsy is done. EAU and NICE guidance supports offering it before biopsy in many cases, because a reassuring result may avoid the need for a biopsy altogether, and an abnormal result helps target the biopsy more precisely. It is a reasonable question to raise with your urologist at the same appointment where the biopsy is discussed.

Can CION help us work through this decision?

Yes. CION's urology and oncology teams see this decision regularly and can review PSA history, imaging and overall health to advise on whether a biopsy is appropriate. If a biopsy is recommended, they will discuss which route is safest. If monitoring is the better choice, they can set up a structured plan. Appointments across CION's 35-plus centres across Telangana and Andhra Pradesh can be coordinated to suit your location.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation